Ascendia Pharmaceuticals articles

In 2022, our team continued its explosive growth on the back of the many successes we’ve achieved in preformulation, formulation, target product profiles, and helping our clients advance their products into the clinic. We’ve done all these things and more – and our numbers reflect that. It was a fitting way to celebrate our 10^th anniversary as one of the industry’s leading specialty CDMO. 

Day in and day out, we co